News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,613 Results
Type
Article (36813)
Company Profile (244)
Press Release (653541)
Multimedia
Podcasts (117)
Webinars (16)
Section
Business (219460)
Career Advice (926)
Deals (33135)
Drug Delivery (101)
Drug Development (76127)
Employer Resources (75)
FDA (15201)
Job Trends (12758)
News (320668)
Policy (25798)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (10)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
40 Under 40 (1)
Academia (2201)
Academic (1)
Accelerated approval (59)
ADA (36)
Adcomms (24)
Allergies (186)
Alliances (49139)
ALS (229)
Alzheimer's disease (1621)
Antibody-drug conjugate (ADC) (643)
Approvals (15915)
Artificial intelligence (859)
ASCO (318)
Autoimmune disease (425)
Automation (71)
Bankruptcy (313)
Belgium (13)
Best Places to Work (10174)
BIO (59)
Biologics (32)
BIOSECURE Act (11)
Biosimilars (183)
BioSpace Insights (130)
Biotechnology (170)
Bispecific (10)
Bladder cancer (223)
Brain cancer (82)
Breast cancer (854)
Cancer (6931)
Cardiovascular disease (434)
Career advice (805)
Career pathing (26)
CAR-T (421)
CDC (22)
CDMO (149)
Celiac Disease (3)
Cell-line development (2)
Cell therapy (1163)
Cervical cancer (54)
Clinical research (67530)
Collaboration (2417)
Commercialization (18)
Company closure (5)
Compensation (1681)
Complete response letters (70)
COVID-19 (2046)
CRISPR (132)
CRO (1)
C-suite (1356)
Cystic fibrosis (161)
Data (9232)
Decentralized trials (3)
Denatured (40)
Depression (153)
Dermatology (134)
Diabetes (602)
Diagnostics (6911)
Digital health (69)
Diversity (8)
Diversity, equity & inclusion (16)
Drug discovery (404)
Drug pricing (57)
Drug shortages (10)
Duchenne muscular dystrophy (296)
Earnings (87101)
Editorial (33)
Employer branding (9)
Employer resources (69)
Events (115719)
Executive appointments (1140)
Eye disease (4)
FDA (19531)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (26)
Frontotemporal dementia (34)
Funding (1904)
Gene editing (279)
Generative AI (68)
Gene therapy (829)
GLP-1 (726)
Government (2494)
Grass and pollen (4)
Guidances (379)
Healthcare (15844)
Hematology (187)
HIV (93)
Huntington's disease (48)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (117)
Immunology and inflammation (297)
Immuno-oncology (130)
Indications (244)
Infectious disease (2377)
Inflammatory bowel disease (223)
Inflation Reduction Act (8)
Influenza (136)
Intellectual property (341)
Interviews (145)
IPO (15525)
IRA (14)
Job creations (2962)
Job search strategy (676)
JPM (44)
Kidney cancer (28)
Kidney disease (93)
Labor market (52)
Layoffs (341)
Leadership (24)
Legal (6314)
Licensing (42)
Liver cancer (106)
Longevity (41)
Lung cancer (1005)
Lung diease (13)
Lymphoma (527)
Machine learning (70)
Management (27)
Manufacturing (1224)
Marketing (13)
MASH (177)
Medical affairs (2)
Medical device (13932)
Medtech (14207)
Mergers & acquisitions (19002)
Metabolic disorders (1299)
mRNA (269)
Multiple sclerosis (210)
Multispecific (3)
NASH (12)
Netherlands (8)
Neurodegenerative disease (469)
Neuropsychiatric disorders (80)
Neuroscience (3246)
NextGen: Class of 2026 (5434)
Non-profit (2525)
Now hiring (37)
Obesity (486)
Opinion (208)
Ovarian cancer (264)
Pain (274)
Pancreatic cancer (378)
Parkinson's disease (399)
Partnered (33)
Patents (689)
Patient advocacy (1)
Patient recruitment (873)
Patient selection (31)
Peanut (65)
People (55763)
Peptides (15)
Pharmaceutical (47)
Pharmacy benefit managers (15)
Phase 1 (22152)
Phase 2 (29981)
Phase 3 (21247)
Pipeline (11725)
Policy (149)
Postmarket research (2080)
Preclinical (9761)
Press Release (70)
Prostate cancer (329)
Psychedelics (36)
Radioligand (1)
Radiopharmaceuticals (370)
Rare diseases (1189)
Real estate (5193)
Recruiting (31)
Regenerative medicine (13)
Regulatory (22780)
Reports (42)
Research institute (2153)
Resumes & cover letters (145)
Rett syndrome (53)
RNA editing (26)
RSV (77)
Schizophrenia (154)
Series A (345)
Series B (231)
Service/supplier (6)
Sickle cell disease (140)
Special edition (14)
Spinal muscular atrophy (156)
Sponsored (43)
Startups (3548)
State (2)
Stem cells (1)
Stomach cancer (19)
Substance use disorders (18)
Supply chain (97)
Switzerland (1)
Tariffs (30)
The Weekly (74)
Vaccines (911)
Venture capital (102)
Weight loss (238)
Wet AMD (2)
Women's health (132)
Worklife (9)
Date
Today (120)
Last 7 days (610)
Last 30 days (2372)
Last 365 days (28728)
2026 (21860)
2025 (28148)
2024 (33049)
2023 (37705)
2022 (48545)
2021 (52159)
2020 (48804)
2019 (39278)
2018 (29518)
2017 (29587)
2016 (28611)
2015 (35113)
2014 (29571)
2013 (25570)
2012 (27441)
2011 (27727)
2010 (26347)
Location
Africa (521)
Alabama (103)
Alaska (7)
Arizona (398)
Arkansas (16)
Asia (38046)
Australia (6293)
California (15157)
Canada (4170)
China (1602)
Colorado (644)
Connecticut (617)
Delaware (406)
Europe (77318)
Florida (2263)
Georgia (471)
Hawaii (4)
Idaho (62)
Illinois (1156)
India (98)
Indiana (539)
Iowa (29)
Japan (681)
Kansas (140)
Kentucky (57)
Louisiana (43)
Maine (94)
Maryland (1680)
Massachusetts (10915)
Michigan (423)
Minnesota (812)
Mississippi (6)
Missouri (156)
Montana (33)
Nebraska (23)
Nevada (156)
New Hampshire (91)
New Jersey (3705)
New Mexico (34)
New York (3867)
North Carolina (1836)
North Dakota (12)
Northern California (7683)
Ohio (448)
Oklahoma (26)
Oregon (34)
Pennsylvania (2934)
Puerto Rico (31)
Rhode Island (55)
South America (807)
South Carolina (96)
South Dakota (1)
Southern California (6145)
Tennessee (220)
Texas (2541)
United States (52534)
Utah (454)
Vermont (2)
Virginia (316)
Washington D.C. (59)
Washington State (1202)
West Virginia (3)
Wisconsin (164)
Wyoming (3)
690,613 Results for "cell signaling technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
June 10, 2026
·
7 min read
Manufacturing
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
Setbacks to efforts to use Cellares’ automated platform to make an approved CAR-T cell therapy led BMS to terminate its partnership with the manufacturing specialist.
August 26, 2026
·
2 min read
·
Nick Paul Taylor
Cell and Gene Therapy
Meeting on the Mesa Arrives Amid Mixed Signals for Cell and Gene Therapy
As industry leaders gather at the annual event in Phoenix, the cell and gene therapy space remains in a state of flux, with M&A activity and regulatory support signaling momentum while commercialization challenges continue to hinder broader investor interest.
October 6, 2025
·
5 min read
·
Ben Hargreaves
Sponsored by Sino Biological
Unlocking cell surface protein research with site-specific labeling
Applications in flow cytometry, cell sorting, target validation, and therapeutic discovery
September 14, 2026
·
8 min read
IN PARTNERSHIP WITH LONGEVITY MEDICAL INSTITUTE
Regenerative medicine needs more than stem cells
Stem cell therapies vary widely yet many physicians still treat them as interchangeable. A more credible model requires diagnostics, product characterization and conventional medical context to determine who and when should receive regenerative treatment.
September 28, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Editorial
Mikhail, Davis embody the FDA’s stabilization, Seehafer signals AI revolution is coming
Newly solidified in their roles as the heads of CBER and CDER, Karim Mikhail and Michael Davis have been working for months to right the ship that had begun to capsize under former Commissioner Marty Makary. Meanwhile, Jared Seehafer will become the first-ever deputy commissioner focused on artificial intelligence.
September 11, 2026
·
5 min read
·
Jef Akst
Press Releases
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
August 26, 2026
·
2 min read
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Sponsored by AGC Biologics
Beyond Random Integration: Transposase cell line development shortening timeline & boosting titers
As molecule complexity rises, advanced cell line development platforms are giving biopharma companies new tools to overcome expression challenges, improve stability and reach the clinic faster.
September 21, 2026
·
7 min read
·
AGC Biologics
Press Releases
K2 Medical Research Appoints Robert Massey as Chief Commercial Officer in Newly Created Role, Signaling Next Chapter of Growth
September 15, 2026
·
4 min read
1 of 69,062
Next